Asia / TAIWAN
Company Overview
Original BioMedicals Co., Ltd. engages in the development of non-new ingredients new drugs. Its products include radiation injury prevention drug with amifostine compound, amifostine combined microcellular chemotherapy adjuvant, and peptide-like compound for the treatment of microcellular diabetes. The company was founded by Chia Hung Chen on December 05, 2011 and is headquartered in Tainan, Taiwan.
Original BioMedicals Co., Ltd. engages in the development of non-new ingredients new drugs. Its products include radiation injury prevention drug with amifostine compound, amifostine combined microcellular chemotherapy adjuvant, and peptide-like compound for the treatment of microcellular diabetes. The company was founded by Chia Hung Chen on December 05, 2011 and is headquartered in Tainan, Taiwan.
Includes quarterly earnings and dividends.
Company Details
| Major Industry | Pharmaceuticals & Biotechnology |
| Sub Industry | Pharmaceutical Preparations |
| Country | TAIWAN |
| Employees | 15 |
| Reporting Unit | Billions |
| Primary Exchange | Unknown exchange |
| Instrument Type | Equity |
| Wright ID | C158WXMT3 |
Key Metrics
| Current price | $15.80 |
| Market cap | $1.06 B |
| P/E ratio | n/a |
| 52-week perf. | +45.6% |
| Common shares | 66.8 M |
| Share type | Gu |
| Quality rating | LBD0 |
| Dividend yield | 0.00% |
Recent stock performance
| 1 Week | +8.2% |
| 4 Week | +20.1% |
| 13 Week | +9.7% |
Officers
n/a
Address
TAIWAN
| Phone | n/a |
Quarterly Earnings & Dividends
Try another report for annual statements, Wright Quality history or comparative analysis.